Biotechnology Business and Science: From Drug Discovery to Financing

Launching a successful biotechnology venture requires a unique blend of cutting-edge science and sophisticated business strategy. Bridging the gap between the laboratory and the market is essential for bringing life-saving therapies to patients. This text-based course provides a comprehensive introduction to the foundational science, clinical development processes, and financial structures that power the modern biotechnology industry. You will develop the skills to evaluate drug discovery pipelines, navigate regulatory pathways, and understand how early-stage biotech startups secure funding. What you'll learn: - Understand the fundamental biological mechanisms and disease targets driving modern drug discovery. - Analyze the business models, corporate structures, and licensing agreements unique to early-stage biotechnology companies. - Evaluate different financing methods, including venture capital, public markets, and strategic pharmaceutical partnerships. - Navigate the phases of clinical trials, regulatory approval pathways, and patient access challenges. - Explore modern trends in biotech, including AI-driven drug discovery and gene-editing platforms. The course begins with core scientific concepts and terminology before transitioning into the business frameworks, valuation methods, and financial models used by industry leaders. You will read real-world scenarios that illustrate how science and capital align to create viable medical products. Designed for beginners, this course requires no prior background in molecular biology or corporate finance. It is ideal for aspiring entrepreneurs, investors, scientists, and business students looking to enter the biotech sector. Start reading today to master the intersection of science, finance, and healthcare innovation.